Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 82

1.

Incidence and risk factors for leptomeningeal carcinomatosis in breast cancer patients with parenchymal brain metastases.

Jung JM, Kim S, Joo J, Shin KH, Gwak HS, Lee SH.

J Korean Neurosurg Soc. 2012 Sep;52(3):193-9. doi: 10.3340/jkns.2012.52.3.193. Epub 2012 Sep 30.

2.

Brain metastases in breast cancer: prognostic factors and management.

Lee SS, Ahn JH, Kim MK, Sym SJ, Gong G, Ahn SD, Kim SB, Kim WK.

Breast Cancer Res Treat. 2008 Oct;111(3):523-30. Epub 2007 Nov 8.

PMID:
17990100
3.

Whole brain radiotherapy in management of non-small-cell lung carcinoma associated leptomeningeal carcinomatosis: evaluation of prognostic factors.

Ozdemir Y, Yildirim BA, Topkan E.

J Neurooncol. 2016 Sep;129(2):329-35. doi: 10.1007/s11060-016-2179-9. Epub 2016 Jun 15.

PMID:
27306442
4.

Risk of leptomeningeal carcinomatosis in patients with brain metastases treated with stereotactic radiosurgery.

Ma R, Levy M, Gui B, Lu SE, Narra V, Goyal S, Danish S, Hanft S, Khan AJ, Malhotra J, Motwani S, Jabbour SK.

J Neurooncol. 2018 Jan;136(2):395-401. doi: 10.1007/s11060-017-2666-7. Epub 2017 Nov 20.

PMID:
29159778
5.

Isolated leptomeningeal carcinomatosis (carcinomatous meningitis) after taxane-induced major remission in patients with advanced breast cancer.

Kosmas C, Malamos NA, Tsavaris NB, Stamataki M, Gregoriou A, Rokana S, Vartholomeou M, Antonopoulos MJ.

Oncology. 2002;63(1):6-15.

PMID:
12187065
6.

Leptomeningeal carcinomatosis after major remission to taxane-based front-line therapy in patients with advanced breast cancer.

Kosmas C, Malamos NA, Tsavaris NB, Stamataki M, Stefanou S, Gregoriou A, Rokana S, Vartholomeou M, Antonopoulos MJ.

J Neurooncol. 2002 Feb;56(3):265-73.

PMID:
12061734
7.

Efaproxiral: GSJ 61, JP 4, KDD 86, RS 4, RSR 13.

[No authors listed]

Drugs R D. 2005;6(3):178-85. Review.

PMID:
15869322
8.

Brain metastases from epithelial ovarian cancer. The Hellenic Cooperative Oncology Group (HeCOG) experience and review of the literature.

Pectasides D, Aravantinos G, Fountzilas G, Kalofonos C, Efstathiou E, Karina M, Pavlidis N, Farmakis D, Economopoulos T, Dimopoulos MA.

Anticancer Res. 2005 Sep-Oct;25(5):3553-8. Review.

9.

Breast cancer subtypes and response to systemic treatment after whole-brain radiotherapy in patients with brain metastases.

NiwiƄska A, Murawska M, Pogoda K.

Cancer. 2010 Sep 15;116(18):4238-47. doi: 10.1002/cncr.25391.

10.

Effects of Postoperative Radiotherapy on Leptomeningeal Carcinomatosis or Dural Metastasis after Resection of Brain Metastases in Breast Cancer Patients.

Ha B, Chung SY, Kim YJ, Gwak HS, Chang JH, Lee SH, Park IH, Lee KS, Lee S, Kim TH, Kim DY, Kang SG, Suh CO.

Cancer Res Treat. 2017 Jul;49(3):748-758. doi: 10.4143/crt.2016.303. Epub 2016 Oct 31.

11.

Incidence of leukoencephalopathy after whole-brain radiation therapy for brain metastases.

Ebi J, Sato H, Nakajima M, Shishido F.

Int J Radiat Oncol Biol Phys. 2013 Apr 1;85(5):1212-7. doi: 10.1016/j.ijrobp.2012.09.025. Epub 2012 Oct 23.

PMID:
23102839
12.

Gastric cancer and metastasis to the brain.

York JE, Stringer J, Ajani JA, Wildrick DM, Gokaslan ZL.

Ann Surg Oncol. 1999 Dec;6(8):771-6.

PMID:
10622506
13.

Second nonbreast malignancies after conservative surgery and radiation therapy for early-stage breast cancer.

Galper S, Gelman R, Recht A, Silver B, Kohli A, Wong JS, Van Buren T, Baldini EH, Harris JR.

Int J Radiat Oncol Biol Phys. 2002 Feb 1;52(2):406-14.

PMID:
11872286
14.

Clinical features and survival analysis of different subtypes of patients with breast cancer brain metastases.

Bai B, Yuan ZY, Liu DG, Teng XY, Wang SS.

Chin J Cancer. 2010 Apr;29(4):413-9.

15.

Incidence, timing, and treatment of new brain metastases after Gamma Knife surgery for limited brain disease: the case for reducing the use of whole-brain radiation therapy.

Rush S, Elliott RE, Morsi A, Mehta N, Spriet J, Narayana A, Donahue B, Parker EC, Golfinos JG.

J Neurosurg. 2011 Jul;115(1):37-48. doi: 10.3171/2011.2.JNS101724. Epub 2011 Mar 18.

PMID:
21417707
16.

Molecular Targeted Therapies for the Treatment of Leptomeningeal Carcinomatosis: Current Evidence and Future Directions.

Lee DW, Lee KH, Kim JW, Keam B.

Int J Mol Sci. 2016 Jul 5;17(7). pii: E1074. doi: 10.3390/ijms17071074. Review.

17.
19.

Central nervous system metastases in women who receive trastuzumab-based therapy for metastatic breast carcinoma.

Bendell JC, Domchek SM, Burstein HJ, Harris L, Younger J, Kuter I, Bunnell C, Rue M, Gelman R, Winer E.

Cancer. 2003 Jun 15;97(12):2972-7.

20.

Adjuvant whole-brain radiation therapy after surgical resection of single brain metastases.

McPherson CM, Suki D, Feiz-Erfan I, Mahajan A, Chang E, Sawaya R, Lang FF.

Neuro Oncol. 2010 Jul;12(7):711-9. doi: 10.1093/neuonc/noq005. Epub 2010 Feb 14.

Supplemental Content

Support Center